This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feng, G. Articles by Lotan, R. Search for Related Content PubMed PubMed Citation Articles by Feng, G. Articles by Lotan, R.

Diminished Expression of S100A2, a Putative Tumor Suppressor, at Early Stage of Human Lung Carcinogenesis¹

Departments of Thoracic/Head & Neck Medical Oncology [G. F., E. M. Y., R. L.] and Clinical Cancer Prevention [X-C. X.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

To identify and understand early events in lung carcinogenesis, we used a cDNA array to screen for genes that are expressed differentially in normal human bronchial epithelial (NHBE) cells and a tumorigenic cell line (1170-I) derived from immortalized HBE cells after exposure to cigarette smoke condensate in vivo. Among these genes, we have identified the S100A2 gene, which encodes a nuclear calcium-binding protein, as being down-regulated in the 1170-I cells. Because this gene has been implicated as a tumor suppressor in breast cancer, we examined its potential role as a tumor suppressor in lung carcinogenesis. Levels of S100A2 transcript and protein, which were high in NHBE cells, decreased by up to 50% in immortalized HBE cells (BEAS-2B and 1799) and to low to nearly undetectable levels in transformed (1198) and tumorigenic (1170-I) HBE cells. Furthermore, S100A2 mRNA and protein were undetectable in 8 and expressed at a reduced level in 3 of 11 non-small cell lung cancer (NSCLC) cell lines. Positive immunohistochemical staining of S100A2 was detected in the majority (75–83%) of normal and hyperplastic lung tissues, whereas it was detected in <10% of metaplastic lung tissues, squamous cell carcinoma, and adenocarcinoma. Treatment of 1170-I HBE and NSCLC cells with 5-aza-2'-deoxycytidine resulted in partial restoration of S100A2 expression in seven of eight cell lines. Indeed, CpG methylation was detected in the promoter region of the S100A2 gene. Our results suggest that S100A2 expression is suppressed early during lung carcinogenesis, possibly by hypermethylation of its promoter, and that its loss may be a contributing factor in lung cancer development or a biomarker of early changes in this process.

This article has been cited by other articles:

				E. Bulk, B. Sargin, U. Krug, A. Hascher, Y. Jun, M. Knop, C. Kerkhoff, V. Gerke, R. Liersch, R. M. Mesters, et al. S100A2 Induces Metastasis in Non-Small Cell Lung Cancer Clin. Cancer Res., January 1, 2009; 15(1): 22 - 29. [Abstract] [Full Text] [PDF]

				R. D. Kirschner, K. Sanger, G. A. Muller, and K. Engeland Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site Nucleic Acids Res., May 1, 2008; 36(9): 2969 - 2980. [Abstract] [Full Text] [PDF]

				J. A. Gollob and C. J. Sciambi Decitabine Up-regulates S100A2 Expression and Synergizes with IFN-{gamma} to Kill Uveal Melanoma Cells Clin. Cancer Res., September 1, 2007; 13(17): 5219 - 5225. [Abstract] [Full Text] [PDF]

				S.-W. Kim, K. Cheon, C.-H. Kim, J.-H. Yoon, D. H. Hawke, R. Kobayashi, L. Prudkin, I. I. Wistuba, R. Lotan, W. K. Hong, et al. Proteomics-Based Identification of Proteins Secreted in Apical Surface Fluid of Squamous Metaplastic Human Tracheobronchial Epithelial Cells Cultured by Three-Dimensional Organotypic Air-Liquid Interface Method Cancer Res., July 15, 2007; 67(14): 6565 - 6573. [Abstract] [Full Text] [PDF]

				W.-C. Tsai, S.-T. Tsai, Y.-T. Jin, and L.-W. Wu Cyclooxygenase-2 Is Involved in S100A2-Mediated Tumor Suppression in Squamous Cell Carcinoma Mol. Cancer Res., August 1, 2006; 4(8): 539 - 547. [Abstract] [Full Text] [PDF]

				A. Mueller, B. W. Schafer, S. Ferrari, M. Weibel, M. Makek, M. Hochli, and C. W. Heizmann The Calcium-binding Protein S100A2 Interacts with p53 and Modulates Its Transcriptional Activity J. Biol. Chem., August 12, 2005; 280(32): 29186 - 29193. [Abstract] [Full Text] [PDF]

				J. B. Vos, M. A. van Sterkenburg, K. F. Rabe, J. Schalkwijk, P. S. Hiemstra, and N. A. Datson Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense Physiol Genomics, May 11, 2005; 21(3): 324 - 336. [Abstract] [Full Text] [PDF]

				T.T.T. Nguyen, E. Tran, T.H. Nguyen, P.T. Do, T.H. Huynh, and H. Huynh The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells Carcinogenesis, May 1, 2004; 25(5): 647 - 659. [Abstract] [Full Text] [PDF]

				K. Hibi, S.-i. Fujitake, T. Takase, Y. Kodera, K. Ito, S. Akiyama, M. Shirane, and A. Nakao Identification of S100A2 as a Target of the {Delta}Np63 Oncogenic Pathway Clin. Cancer Res., September 15, 2003; 9(11): 4282 - 4285. [Abstract] [Full Text] [PDF]

				S. Gupta, T. Hussain, G. T. MacLennan, P. Fu, J. Patel, and H. Mukhtar Differential Expression of S100A2 and S100A4 During Progression of Human Prostate Adenocarcinoma J. Clin. Oncol., January 1, 2003; 21(1): 106 - 112. [Abstract] [Full Text] [PDF]

				W.'e. El-Rifai, C. A. Moskaluk, M. K. Abdrabbo, J. Harper, C. Yoshida, G. J. Riggins, H. F. Frierson Jr., and S. M. Powell Gastric Cancers Overexpress S100A Calcium-binding Proteins Cancer Res., December 1, 2002; 62(23): 6823 - 6826. [Abstract] [Full Text] [PDF]

				G. Fontemaggi, I. Kela, N. Amariglio, G. Rechavi, J. Krishnamurthy, S. Strano, A. Sacchi, D. Givol, and G. Blandino Identification of Direct p73 Target Genes Combining DNA Microarray and Chromatin Immunoprecipitation Analyses J. Biol. Chem., November 1, 2002; 277(45): 43359 - 43368. [Abstract] [Full Text] [PDF]